Snowball logo
logo
AQSZ

Aequus Pharmaceuticals Inc

AQSZF OTCQB
$0.0012$0.00  (0%)
Estimate
EPS
-0.01
Beta
-0.207
About the company
Ticker
AQSZF
ISIN
Country
Canada
Sector (GICS)
Healthcare
Aequus Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada. The company offers ZIMED PF, a preservative-free bimatoprost prescription drug for the for the reduction of elevated interocular pressure in patients with open angle glaucoma or ocular hypertension. It also develops REV-0100, which is in pre-clinical trial for the treatment of stargardt disease. Aequus Pharmaceuticals Inc. was incorporated in 2013 and is headquartered in Vancouver, Canada.

Frequently asked questions

What sector does Aequus Pharmaceuticals Inc (AQSZF) operate in?

Aequus Pharmaceuticals Inc belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.

What is Aequus Pharmaceuticals Inc (AQSZF) current stock price?

As of the latest data, Aequus Pharmaceuticals Inc stock price is $0.00, with a previous close of $0.00.

What is Aequus Pharmaceuticals Inc (AQSZF) current market capitalization?

Aequus Pharmaceuticals Inc market cap is approximately 159.16 thousand.

What is Aequus Pharmaceuticals Inc (AQSZF) Earnings Per Share (EPS)?

The trailing EPS is -$0.01.

Does Aequus Pharmaceuticals Inc (AQSZF) pay dividends?

No. Aequus Pharmaceuticals Inc does not pay a dividend.

When is Aequus Pharmaceuticals Inc (AQSZF) next earnings report?

Aequus Pharmaceuticals Inc is expected to release its next earnings report on June 30, 2026.

What is Aequus Pharmaceuticals Inc (AQSZF) beta (volatility) score?

Aequus Pharmaceuticals Inc has a beta of -0.207, indicating lower volatility than the overall market.